BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Nereus Pharmaceuticals, Inc. 

10480 Wateridge Circle

San Diego  California  92121  U.S.A.
Phone: 858-587-4090 Fax: 858-587-4088


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Nereus Pharmaceuticals, Inc. Raises $20 Million 6/23/2010 7:26:09 AM    More...
Nereus Pharmaceuticals, Inc. Completes Enrollment of Phase 2 ADVANCE Clinical Trial of Plinabulin in Non-Small Cell Lung Cancer 6/22/2010 8:48:47 AM    More...
Nereus Pharmaceuticals, Inc. Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference 11/23/2009 9:52:24 AM    More...
Nereus Pharmaceuticals, Inc. Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer 3/23/2009 8:34:37 AM    More...
Nereus Pharmaceuticals, Inc. Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors 4/18/2008 8:44:52 AM    More...
Nereus Pharmaceuticals, Inc. Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 3/20/2008 6:43:56 AM    More...
Nereus Pharmaceuticals, Inc.'s NPI-0052 Named One of the Industry's Top Ten Unpartnered Oncology Drug Candidates 10/16/2007 8:17:55 AM    More...
Nereus Pharmaceuticals, Inc. Raises $45 Million in Series D-2 Financing 8/9/2007 7:36:29 AM    More...
The Multiple Myeloma Research Consortium and Nereus Pharmaceuticals, Inc. Initiate Clinical Trial Investigating NPI-0052 to Treat Multiple Myeloma 4/16/2007 11:44:26 AM    More...
Nereus Pharmaceuticals, Inc. to Present Data at the American Association for Cancer Research 2007 Annual Meeting 4/9/2007 1:40:45 PM    More...
12

//-->